Tanyeri, Pelin; Büyükokuroğlu, Mehmet Emin; Oguz Mutlu; Guner Ulak; Furuzan Yildiz Akar; Ipek Komsuoglu Celikyurt; Bekir Faruk Erden
(PERGAMON-ELSEVIER SCIENCE LTD, 2015)
Conclusions: The second-generation antipsychotic drug ziprasidone and D1 antagonist SCH23390, but not the D3 antagonist SB277011, might be clinically useful for the treatment of cognitive impairments in patients with ...